Mucormycosis and COVID-19: A systematic review

Identifying factors that contribute to the progression of COVID-19 in patients is crucial for preventing fatalities. Mucormycosis is one such influential factor. Hence, this study aimed to conduct a systematic review on the correlation between black fungus infection and COVID 19.

This systematic review followed the PRISMA protocol and utilized international databases.

A total of 161 cases were documented among 7495 COVID-19 patients. The majority of cases were reported in India. Among the case reports, 16 (76%) were male and six (24%) were female. Diabetes mellitus was prevalent in 56% of cases, with hypertension being the second most common comorbidity. Rhinocerebral mucormycosis emerged as the most prevalent clinical form of the disease.

Timely identification of mucormycosis cases, monitoring of hyperglycemia, appropriate use of antibiotics, and corticosteroids can help curb the rising incidence of this fungal infection.